Business Context and Reporting Period
This Form 8-K Current Report from Corbus Pharmaceuticals Holdings, Inc. (CRBP) covers events occurring on June 17, 2021, specifically the Company's Annual Meeting of Stockholders. The filing details the outcomes of shareholder votes and a subsequent amendment to the Company's Certificate of Incorporation.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Corporate Actions
- Charter Amendment Approved: Stockholders voted to increase the Company's authorized shares of common stock from 150,000,000 to 300,000,000. The amendment was filed with the Delaware Secretary of State on June 17, 2021.
- Director Elections: Six directors were elected to one-year terms: Dr. Yuval Cohen, Alan Holmer, Avery W. Catlin, Peter Salzmann, John Jenkins, and Rachelle Jacques.
- Accounting Firm Ratification: Stockholders ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
- Executive Compensation: The advisory vote on executive compensation was approved.
Voting Results Summary
| Proposal | Votes For | Votes Against | Abstentions |
|---|---|---|---|
| Ratify Auditor (EisnerAmper LLP) | 72,865,397 | 662,723 | 757,255 |
| Executive Compensation (Advisory) | 36,346,860 | 4,599,776 | 634,982 |
| Charter Amendment (Increase Authorized Shares) | 64,140,597 | 9,691,289 | 453,489 |
Note: Broker non-votes of 32,703,757 were recorded for the director elections and executive compensation proposal but did not affect the outcome of the charter amendment or auditor ratification.
Guidance, Outlook, and Risks
This filing does not provide financial guidance, management commentary on business outlook, or specific risk factors. It strictly reports on the procedural outcomes of the Annual Meeting.
Key Facts for Investor Verification
- Verify the effective date of the Charter Amendment (June 17, 2021) and the new authorized share count (300,000,000) in the Company's updated corporate filings.
- Review the definitive proxy statement (Schedule 14A filed April 6, 2021) for detailed terms regarding the Charter Amendment and executive compensation.
- Confirm the composition of the Board of Directors for the upcoming term based on the election results listed above.
- Note that this document contains no financial data; refer to the most recent 10-Q or 10-K for financial performance metrics.